Pharmaceutical

Novo Nordisk enters deal to develop obesity therapy

Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biotechnologies to develop therapeutics for obesity.

May 11, 2024 - 04:00
Novo Nordisk enters deal to develop obesity therapy
Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biotechnologies to develop therapeutics for obesity.
Read the original article

Tags:

Previous Article

Attovia secures $105m to advance development of lead programmes

Next Article

KITECH develops deformable energy storage device via laser technology

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Listen: Sniffing out the power, and limits, of the placebo effect

Opinion: Listen: Sniffing out the power, and limits, of...

Nov 1, 2023

STAT+: Hospitals struggle to make money on CAR-T cancer therapies, but their fortunes may change

STAT+: Hospitals struggle to make money on CAR-T cancer...

Jul 20, 2023

Biotechs must prioritise ethics to deter GenAI “bad actors”

Biotechs must prioritise ethics to deter GenAI “bad act...

May 9, 2024